Analyzing the effect of the COVID-19 vaccine on Parkinson’s disease symptoms

ABSTRACT:

Background

Parkinson’s Disease (PD) is one of the most common neurodegenerative diseases. PD has recently received more attention by researchers in the midst of the COVID-19 pandemic.

Objective

Yet to be researched is the effect of the COVID-19 vaccines on PD patients. Several PD patients are still hesitant to the vaccine due to this unaddressed fear. The purpose of this study is to address this gap.

Methods

Surveys were administered to PD patients 50 years and older at UF Fixel Institute who received at least one dose of the COVID-19 vaccine. Survey questions included patients’ severity of PD symptoms before and after the vaccine and extent of worsening PD symptoms post-vaccination. After three weeks of collecting responses, the data was analyzed.

Results

SUBMITTER: Sabat R 

PROVIDER: S-EPMC10278957 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature